Radiation Oncology/Therapy: Page 342

TomoTherapy, Medical Intelligence partner
By AuntMinnie.com staff writers
Radiation therapy firm TomoTherapy of Madison, WI, has formed a partnership with Elekta subsidiary Medical Intelligence aimed at improving the stereotactic radiosurgery capabilities of TomoTherapy's Hi-Art treatment system.
October 29, 2007
ASTRO studies assess CT's reliability pre- and postradiotherapy in breast, brain, lung
By Shalmali Pal
LOS ANGELES - As radiation oncologists continue to push the envelope with dose escalation, imaging guidance becomes an indispensable tool for treatment planning, assessing response relationships, and, ultimately, reducing morbidity. To that end, three presentations at this week's American Society for Therapeutic Radiology and Oncology (ASTRO) meeting looked at the role CT plays in targeting and planning.
October 29, 2007
Vision RT nets FDA OK and several U.S. sales
By AuntMinnie.com staff writers
U.K. radiation therapy developer Vision RT has received 510(k) clearance from the Food and Drug Administration (FDA) to market its GateCT and GateRT devices in the U.S.
October 28, 2007
Philips to show large-bore PET/CT at ASTRO
By AuntMinnie.com staff writers
Philips Medical Systems of Andover, MA, will unveil a new large-bore PET/CT system as a work-in-progress at this year's annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Los Angeles.
October 28, 2007
Carestream to highlight PACS features at ASTRO
By AuntMinnie.com staff writers
Carestream Health of Rochester, NY, plans to demonstrate advanced features for its Kodak Carestream PACS at the American Society for Therapeutic Radiology and Oncology (ASTRO) meeting in Los Angeles.
October 25, 2007
Varian to launch new IMRT at ASTRO
By AuntMinnie.com staff writers
Varian Medical Systems of Palo Alto, CA, plans to launch a new technology for treating cancer patients with intensity-modulated radiotherapy (IMRT) at the upcoming meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Los Angeles.
October 24, 2007
Lung function guides IMRT planning
Non-small cell lung cancer (NSCLC) is particularly difficult to treat with radiotherapy as healthy lung tissue may not tolerate the radiation dose required to control tumor growth. Lowering the optimum dose leaves the cancer strong enough to spread, but without the downward adjustment, patients face unpleasant side effects. Inclusion of lung function information into treatment plans could offer big benefits for lung cancer patients.
October 23, 2007
2007 09 14 10 50 59 706
UPMC starts Leksell treatments
By AuntMinnie.com staff writers
Patient treatments have begun at the Center for Image-Guided Neurosurgery at the University of Pittsburgh Medical Center (UPMC) Presbyterian with the Leksell Gamma Knife Perfexion system from Stockholm, Sweden-based Elekta.
October 22, 2007
TomoTherapy, RaySearch partner
By AuntMinnie.com staff writers
Radiation therapy firm TomoTherapy has formed a strategic collaboration with Swedish radiation therapy software developer RaySearch Laboratories.
October 22, 2007
RTS to be acquired by equity firm
By AuntMinnie.com staff writers
Private equity firm Vestar Capital Partners has inked an agreement to acquire oncology treatment center operator Radiation Therapy Services in a deal valued at $1.1 billion.
October 21, 2007
Local control matters for long-term breast cancer survival
By Kate Madden Yee
When it comes to breast cancer, whether local treatment improves a woman's long-term survival rates has been a point of debate for decades, according to Dr. Jay Harris, chair of radiation oncology at the Dana-Farber/Brigham and Women's Cancer Center in Boston. Harris made the case that local control does matter at the recent 2007 Breast Cancer Symposium in San Francisco.
October 18, 2007
2007 10 01 09 05 35 706
Elekta to introduce new VMAT at ASTRO show
By AuntMinnie.com staff writers
Radiation oncology firm Elekta of Stockholm, Sweden, will launch a new clinical volumetric intensity-modulated arc therapy (VMAT) product at the upcoming meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), the company announced.
October 17, 2007
Previous Page
Page 342 of 469
Next Page